학술논문
In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease
Document Type
Artikel
Author
Source
Blood cancer journal. 14(1):65
Subject
Language
English
English
English
ISSN
2044-5385